NEURO-LOGIC 2027 is a commercial forum at the intersection of computational neuroscience, brain-computer interfaces (BCI), and global capital. As the flagship event in the Synerg Events portfolio, it serves as the critical bridge between cutting-edge “mind-machine” innovation and scalable clinical and pharmaceutical deployment.
In a market where neurotechnology and AI-driven brain health solutions are poised for explosive growth, NEURO-LOGIC 2027 focuses exclusively on commercialization, regulation, investment, and scaling. We move decisively beyond scientific discovery to the practical realities of deal-making, regulatory pathways, reimbursement strategies, and go-to-market execution, accelerating the partnerships and capital flows that will shape the next decade of precision brain health.
This is not another academic conference. It is a tightly curated business summit engineered for senior decision-makers who are actively deploying capital, acquiring technologies, and bringing neuro-AI solutions to market.
